Compound 1110
Identifiers
- Canonical SMILES:
OC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccc(cc1Cl)N(=O)=O
- IUPAC name:
(2S)-2-[(2-chloro-4-nitrobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid
- InChi:
InChI=1S/C18H14ClN3O5/c19-14-8-11(22(26)27)5-6-13(14)17(23)21-16(18(24)25)7-10-9-20-15-4-2-1-3-12(10)15/h1-6,8-9,16,20H,7H2,(H,21,23)(H,24,25)/t16-/m0/s1
- InChiKey:
HWKIYEAXHWCEFZ-INIZCTEOSA-N
External links
![]() 44305159 |
![]() CHEMBL304699 |
![]() 23156062 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
LFA / ICAM | 5.28 | immune system disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 387.06 g/mol | |||
HBA | 8 | |||
HBD | 3 | |||
HBA + HBD | 11 | |||
AlogP | 3.39 | |||
TPSA | 128.01 | |||
RB | 6 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7194 | Rebamipide | DB11656 | |
0.6644 | Oglufanide | DB05779 | |
0.6643 | Golotimod | DB05475 | |
0.6412 | N-[1H-INDOL-3-YL-ACETYL]VALINE ACID | DB07953 | |
0.6259 | N-(indole-3-acetyl)-L-aspartic acid | DB07951 | |
0.6216 | Gramicidin D | DB00027 | |
0.6080 | D-Tryptophan | DB03225 | |
0.6080 | Tryptophan | DB00150 | |
0.6077 | N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID | DB07952 | |
0.6028 | (2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid | DB03605 | |
0.5954 | Beta-Hydroxytryptophane | DB04159 | |
0.5949 | Somatoprim | DB12777 | |
0.5909 | Oxitriptan | DB02959 | |
0.5875 | Murepavadin | DB14777 | |
0.5790 | Indoximod | DB12827 |